Health Care • Biotechnology: Pharmaceutical Preparations
$3.44 ▲ +0.09
(+2.69%)
MKT CAP: $366.9M • VOL: 1.61M
52W L $2 52W H $8
ROARABLE / RQD
D • 44/100
PIOTROSKI
1 / 9
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
RLMD // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>)
SPOT: $3.44
Relmada Therapeutics Inc. (RLMD) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).